Mycofit, 250 mg, kapsułki twarde, volrustomig, Saline, Remsima 100 mg powder for concentrate for solution for infusion
D7984C00002
Phase 3 small_molecule active
Quick answer
Mycofit, 250 mg, kapsułki twarde, volrustomig, Saline, Remsima 100 mg powder for concentrate for solution for infusion for Locally advanced cervical cancer is a Phase 3 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Locally advanced cervical cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active